Mediwound to temporarily suspend initiation of additional clinical sites, new patient enrollment in u.s. escharex phase 2 study for venous leg ulcers

Mediwound - to temporarily suspend initiation of additional clinical sites, new patient enrollment in u.s. escharex phase 2 study for venous leg ulcers.mediwound ltd - existing escharex clinical sites are continuing to manage randomized patients currently on treatment.mediwound ltd - does not anticipate a change to its 2020 cash use guidance as a result of covid-19.
MDWD Ratings Summary
MDWD Quant Ranking